Rezivertinib analogue 1
Rezivertinib analogue 1 is a process impurity of osimertinib mesylate. Rezivertinib analogue 1 can be used in the study of non-small cell lung cancer[1].
Product Specifications
CAS Number
[2227103-37-7]
UNSPSC
12352005
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rezivertinib-analogue-1.html
Concentration
10mM
Purity
99.00
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C)NC1=CC(NC2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C(C=C1N(CCN(C)C)C)OC
Molecular Formula
C27H33N7O2
Molecular Weight
487.60
References & Citations
[1] Huijuan Jia, et al. The methanesulfonic acid uncommon preparation method for Buddhist nun's process contaminants difficult to understand. Patent CN108017620A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
227086-ML650 100 µL
Myeloperoxidase (Myeloperoxidase light chain, Myeloperoxidase heavy chain, MPO) (MaxLight 650) discontinued
Ask
View Details 
GTR15378688 1 Vial
Lentiviral human MMP9 sgRNA gene knockout kit - Lentiviral human MMP9 sgRNA gene knockout kit (100)
Ask
View Details